Sarepta Therapeutics, Inc. SRPT Payments Related To Obtaining Revolving Credit Facility
Payments Related To Obtaining Revolving Credit Facility at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:PaymentsRelatedToObtainingRevolvingCreditFacility.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s payments related to obtaining revolving credit facility.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s payments related to obtaining revolving credit facility?
- Sarepta Therapeutics, Inc. (SRPT) reported payments related to obtaining revolving credit facility of $0 in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s payments related to obtaining revolving credit facility changed year-over-year?
- Sarepta Therapeutics, Inc.'s payments related to obtaining revolving credit facility decreased by 100.0% year-over-year, from $3.21M to $0.
- What does payments related to obtaining revolving credit facility mean?
- Captures the transaction costs, such as legal and administrative fees, incurred to secure or renew revolving credit facilities. Monitoring these costs helps assess the company's expense burden in maintaining liquidity and financial flexibility.